“My liver test was up — but I barely drink, so it can’t be my liver”

A mildly raised ALT (hepatocellular pattern) with central obesity, pre-diabetes and raised triglycerides, minimal alcohol and a negative viral/autoimmune/iron screen is non-alcoholic fatty liver disease (NAFLD/MAFLD) — metabolic, not alcohol — so "I barely drink so it can’t be my liver" is the misconception to correct. The examinable clinical point is to assess FIBROSIS RISK (FIB-4 score per BSG/BASL 2018, ELF test per NICE NG49 with 10.51 or above indicating advanced fibrosis, ultrasound) rather than merely re-checking the ALT or reassuring — because the ALT level does NOT reflect fibrosis severity (advanced fibrosis can occur with near-normal ALT). NAFLD is a metabolic-syndrome and cardiovascular-risk marker, so manage the WHOLE picture (weight/lifestyle as the key, largely-reversible treatment, plus BP, glucose, lipids, CVD risk), refer to hepatology if significant fibrosis. The hidden agenda is defensiveness masking avoidance of the weight/lifestyle conversation and a fear of being judged or that "liver" means something sinister; reframe without blame ("a fixable warning, treating five things with one plan"), give honest proportionate reassurance balanced with proper fibrosis assessment, and follow up. NAFLD is common and often benign, but a subset progress to non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. The key is to assess FIBROSIS RISK (e.g. a FIB-4 score (BSG/BASL 2018), or an enhanced liver fibrosis/ELF test per NICE NG49, where ELF 10.51 or above indicates advanced fibrosis) rather than just reassure or re-check the ALT — and crucially, the ALT level does NOT reflect fibrosis severity (you can have advanced fibrosis with near-normal ALT).